Health Care/Hospital

Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors

New capabilities and simple, standard site experience cut trial time and expense Fixed price implementation to get up and running quickly Industry advances to connected trials as seven of the top 20 biopharmas adopt Veeva Site Connect SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Veeva System...

2024-09-09 08:00 1431

Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors

New capabilities and simple, standard site experience cut trial time and expense Fixed price implementation to get up and running quickly Industry advances to connected trials as  seven of the top 20 biopharmas adopt Veeva Site Connect SYDNEY, Sept. 9, 2024 /PRNewswire/ -- Veeva Systems

2024-09-09 07:00 1419

Perioperative Ivonescimab (PD-1/VEGF) for NSCLC Demonstrated Clinically Significant Phase II Results, Presented in Oral Session at WCLC 2024

HONG KONG, Sept. 8, 2024 /PRNewswire/ -- Akeso (9926. HK) announced that its internally developed PD-1/VEGF bispecific antibody ivonescimab showed clinically significant results from a Phase II study, either as a monotherapy or in combination with chemotherapy, for the perioperative treatment of ...

2024-09-09 02:17 1409

Bc Babycare Marks a Stellar Debut at Germany's Kind+Jugend 2024

COLOGNE, Germany, Sept. 6, 2024 /PRNewswire/ -- Bc Babycare, a leader in innovative products for mothers and babies, made a remarkable debut at Kind+Jugend 2024, the premier international trade fair for baby and toddler outfitting, which opened inCologne, Germany, on September 3. The brand capti...

2024-09-06 23:22 1779

Vieworks Unveils Digital Pathology Scanner LUCEON at ECP 2024

ANYANG-SI, South Korea, Sept. 6, 2024 /PRNewswire/ -- Vieworks, a leading name in bioimaging solutions, is to set a new standard in the digital pathology field with the launch of its high-speed slide scanner LUCEON 510. Vieworks will be making its debut as a digital pathology solution provider at...

2024-09-06 22:00 5361

Daily Eye Care Upgrade: Simmpo Anti-Blue Light Screen Protectors Meet TÜV Rheinland 80% Blue Light Reduction Certification

TAIPEI, Sept. 6, 2024 /PRNewswire/ -- On August 29, Mustard Seed Design Co., Ltd.'s Simmpo brand launched its latest S80 series of anti-blue light screen protectors, available in both AR and matte versions, which have been certified by TÜV Rheinland with the "80% Blue Light Reduction" certificati...

2024-09-06 20:43 3956

City of Riyadh Gears Up to Unveil the Future of Healthcare: Global Health Exhibition

* Kingdom of Saudi Arabia to host Global Health Exhibition (21-23 October 2024 ), a major international event at a venue double the size with over 100,000 attendees and 1,200 exhibiting companies and brands to join in Malham,Riyadh * Event will host 500+ expert speakers across multiple healthca...

2024-09-06 12:00 1303

City of Riyadh Gears Up to Unveil the Future of Healthcare: Global Health Exhibition

* Kingdom of Saudi Arabia to host Global Health Exhibition (21-23 October 2024 ), a major international event at a venue double the size with over 100,000 attendees and 1,200 exhibiting companies and brands to join in Malham,Riyadh * Event will host 500+ expert speakers across multiple healthca...

2024-09-06 12:00 1442

Sciwind Biosciences Announces Oral Presentations at the European Association for the Study of Diabetes 60th Annual Meeting (EASD 2024)

HANGZHOU, China and SAN FRANCISCO, Sept. 6, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease, today announced that the company will present positive results from a ...

2024-09-06 10:10 1917

Akeso to Present Data from 13 Clinical Studies at ESMO 2024, Featuring its Internally Developed Cadonilimab, Ivonescimab, Ligufalimab, and other I/O Antibodies

HONG KONG, Sept. 5, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) will showcase promising results from 13 clinical studies on its internally developed PD-1/CTLA-4 bispecific antibody cadonilimab, PD-1/VEGF bispecific antibody ivonescimab, next-generation CD47 monoclonal antibody ligufalimab, and co...

2024-09-06 08:54 1437

Baird Medical and ExcelFin Acquisition Corp Announce Effectiveness of Registration Statement

FORT MILL, S.C., Sept. 5, 2024 /PRNewswire/ -- Betters Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, and ExcelFin Acquisition Corp. ("ExcelFin") (NASDAQ:XFIN

2024-09-06 05:23 2837

A Small Step towards a Big Mission! World's First! UltraDx Received First Clinical Approval of Single-Molecule Analyzer, in China

SHANGHAI, Sept. 5, 2024 /PRNewswire/ -- UltraDx Bio is proud to announce that its flagship product, the UD-X™ Fully Automated Single-Molecule Array Fluorescence Immunoassay Analyzer, has received its first clinical registration approval inChina. This groundbreaking achievement is now officially l...

2024-09-05 20:35 1941

Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation

* Medera is a clinical-stage biotechnology company focused on targeting difficult-to-treat cardiovascular diseases using a range of next-generation gene- and cell-based approaches in combination with bioengineered human mini-heart drug discovery and screening technology platforms * Transactio...

2024-09-05 20:00 2443

Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business

* TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry * The company serves blue-chip clients in Europe  * TTP Group employs 1,000 people across 27 locations under the operational brands Pharmaplan and Triplan * Exyte CEO Büchele: "With the acquisitio...

2024-09-05 17:00 1404

Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study

HANGZHOU, China, Sept. 5, 2024 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus Medtech, 02500.HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies inChina, announced that its in-house developed next-generation balloon-expandable dry-tissue tra...

2024-09-05 16:56 1495

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

NANJING, China, Sept. 5, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the Breakthrough Therapy designation by the U....

2024-09-05 13:49 1199

Qisda Corporation Wins Asia Responsible Enterprise Award 2024 for Corporate Sustainability Reporting, Showcasing Pioneering Qualities in its Business Operations

SINGAPORE, Sept. 4, 2024 /PRNewswire/ -- Qisda Corporation's commitment to corporate sustainability has recently been recognized at the prestigious Asia Responsible Enterprise Awards (AREA) 2024, organized by Enterprise Asia . Founded in 1984 with its headquarters established in Taoyuan,Taiwan, Qi...

2024-09-05 10:41 1589

The Vietnam Small Animal Veterinary Association (VSAVA) and South Korea's NEL Animal Medical Foundation have joined forces to strengthen international cooperation in veterinary medicine

HO CHI MINH, Vietnam, Sept. 5, 2024 /PRNewswire/ -- Saigon Ventures Co., Ltd. facilitated the signing of a Memorandum of Understanding (MOU) betweenSouth Korea's NEL Animal Medical Foundation (formerly NEL Animal Medical Center) and the Vietnam Small Animal Veterinary Association (VSAVA) to promo...

2024-09-05 10:00 1644

Affinity Equity Partners concludes its successful investment in Island Hospital Sdn Bhd

Affinity Equity Partners is exiting its controlling stake in Island Hospital Sdn. Bhd. SINGAPORE, Sept. 5, 2024 /PRNewswire/ -- Affinity Equity Partners-led consortium has entered into a definitive sales and purchase agreement to fully divest its 100% stake in Island Hospital Sdn. Bhd. ("Island ...

2024-09-05 09:00 1681

Veeva Vault CRM Suite to Unlock Greater Customer Centricity with Launch of Service Center

Expanded suite to unify sales, marketing, medical and service through a connected software and data foundation SINGAPORE, Sept. 5, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Vault CRM Service Center

2024-09-05 09:00 1671
1 ... 38394041424344 ... 847

Week's Top Stories